Home

Pharma China Web Edition

Pharma China Archives

Online Databases

Subscription/Order/Info

Event Calendar

China Pharma Providers

About Us

	News     The Market     Industry News     Regulatory News     General Health     Legal/IPR News     Product/R&D News     API/Bulk Drug News     People in the News     Other News     Top News Worldwide Feature articles     Editorials     Commentaries     Expert Opinions     Interviews     Case Studies     Company Profiles     Editor´s Picks Full Text Title

The Market Industry News Regulatory News General Health Legal/IPR News Product/R&D News API/Bulk Drug News People in the News Other News Top News Worldwide Editorials Commentaries Expert Opinions Interviews Case Studies Company Profiles Editor´s Picks

Is Renewed MNC Optimism in China Sustainable amid Intensified Cost Containment a... Chief Editor James Shen offers his monthly review of the Chinese healthcare sector with this issue's emphasis on deciphering accelerated growth of MNC China business in r... (12/3/2018) Hong Kong Could Become A Hub for Genetics-Based Drugs Discovery. Just One Hitch - Would Beijing Stand in Way? (12/12/2018) Wuxi AppTec Says US Hurdles Will Not Dim Acquisition Appetite (12/5/2018) BeiGene Mounts Its Assault On The Ibrutinib Hegemony (12/5/2018) US Biotech Firms Made China's Gene-Edited Babies Possible (12/4/2018) U.S.-China Trade Tensions Threaten Biotech Cash Surge (12/4/2018) J&J to Build Blood-Cancer Push With Controversial China Biotech (12/4/2018) Is Renewed MNC Optimism in China Sustainable amid Intensified Cost Containment and Slowing Economy? (12/3/2018) Who Are the Investors Supporting He Jiankui, the Chinese Scientist behind the Gene-edited Babies? (11/29/2018) WSJ: Drugmakers Gain More Access to China, But at a Price (11/27/2018) Gene-Edited Babies: China Wants To Be The World Leader, But At What Cost? (11/26/2018) China Pins Its Hopes on Beating US in Race for Bio-Intelligence Supremacy (11/26/2018) Trump Administration Accuses China of Unfairly Using Venture Capital to Acquire American Biotech (11/22/2018) How China Will Handle Its Trade War With the United States in 2019 (11/15/2018) CFIUS Broadens Coverage of Cross-Border Biotech Transactions (11/13/2018) China's Crackdown on Genetics Breaches Could Deter Data Sharing (11/13/2018) Recent Official and Executive Moves  (12/14/2018) NHC Set to Launch National Adjuvant Drug...  (12/14/2018) Promising Phase 3 Results For Green Vall...  (12/13/2018) State Council Passes Final Draft of 4th ...  (12/13/2018) JW Therapeutics Opens R&D Center in ...  (12/13/2018) Innovent Announces Positive Outcome of T...  (12/13/2018) (free) WuXi AppTec Failed to Shine on HKEx Debu...  (12/13/2018) (free) Zai Lab Announces Acceptance of Its NDA ...  (12/12/2018) IntelGenx Partners with Gensco Pharma to...  (12/12/2018) Actelion Granted Chinese Approval for PA...  (12/12/2018) Luye Pharma Files IND for CNS Drug LY030...  (12/12/2018) USFDA Warns Zhejiang Huahai for Failure ...  (12/11/2018) Aurobindo Subsidiary and Luoxin Agree to...  (12/11/2018) Junshi Biosciences Aims to Raise $414M i...  (12/11/2018) Lonza to Establish Strategic Biomanufact...  (12/11/2018) Top 25 Global Pharmaceutical Companies by Market Cap 201... CANbridge Receives IND Approval to Commence CAN008 Phase... Global Contract Pharmaceutical Manufacturing Market to R... White House Task Force Echoes Pharma Proposals Pharma Industry Reputation Rebounds Somewhat in 2016 NH Reports on Chinese OTC Sleep Aids Market in MAT Q3/2018 NH: Chinese OTC Market Growth Steady in MAT Q3 2018, Outpacing ... SMEI President Predicts Continued Chinese Pharma Growth in 2019... China Faces Flu Vaccines Shortage amid Rising Demand and Manufa... IQVIA: The Chinese Pharmaceutical Market to Grow at 5.5% CAGR b... JW Therapeutics Opens R&D Center in Shanghai WuXi AppTec Failed to Shine on HKEx Debut IntelGenx Partners with Gensco Pharma to Market RIZAPORT in ... Actelion Granted Chinese Approval for PAH Drug Uptravi (Sele... Aurobindo Subsidiary and Luoxin Agree to Form Chinese JV SAMR Fines Three Violators as It Steps Up Anti-monopoly ... NMPA Issues Announcement for One-time Import of Referenc... MOFCOM Solicits Comments on Draft Guidelines for Nationa... National Pharmacopoeia Commission Solicits Comments on G... CDE Solicits Comments on Guideline for Clinical Research... State Council Passes Final Draft of 4th Amendment of Chinese... State Council Approves Patent Amendment Draft and Policies t... China Introduces A Range of New Punishments for IP Violation... NMPA Signs MOU with MPP after Joining WHO’s COPP President Xi Pledges to Protect IP and Boost Import at 1st I... USFDA Warns Zhejiang Huahai for Failure to Detect Valsar... Chinese Heparin Maker Yibin Lihao Bio Banned by EMA over... Huahai Pharma Faces Lawsuits on Cancer-Causing Valsartan... Zheijiang Huahai Placed under Increased Supervision EU, U.S. and Canada Investigating Second Impurity in Hua... Promising Phase 3 Results For Green Valley’s Alzheimer’... Innovent Announces Positive Outcome of Two Clinical Stud... Zai Lab Announces Acceptance of Its NDA for ZEJULA (Nira... Luye Pharma Files IND for CNS Drug LY03003 in Japan Innovent Gains US FDA Approval to Initiate Clinical Tria... NHC Set to Launch National Adjuvant Drug List Soon National Centralized Drug Purchase Trial Upsets Pharma I... NHC and SMIA Reach Consensus about Use of HTA for BMI Re... NHC and SATCM Issue New Pharmacy Service Policy, Banning... NHC: HIV/AIDS Rate at Low Level in China Recent Official and Executive Moves Recent Executive Moves Recent Official and Executive Moves Recent Executive Moves Recent Executive Moves China to Launch New Tech Bourse in Shanghai Upcoming Event: 2nd International Conference on Vaccines... Upcoming Event: 31st Annual Cardiologists Conference Upcoming Event: Phar-East 2019 Upcoming Event: Health Insurance Innovation Congress Asi... Pharma China is the most influential English media and source of business intelligence covering the Chinese pharmaceutical and biopharmaceutical sector... WiCON has been helping international healthcare companies succeed in China and other Asian markets since 1991. We advise our clients on every stage of their China and Asian business. We worked with clients in many regions of the world...   WiCON Publishes the China Phar...   WiCON Officially Publishes Chi...   WiCON Officially Publishes Chi...   WiCON and PharmaGuys Launch Ph...   WiCON Officially Publishes Chi...

© Wicon International Group  Support by: www.heightow.com Site map | Contact Us | Links